Nasdaq:US$36.45 (-2.83) | HKEX:HK$60.55 (+0.00) | AIM:£5.37 (-0.28)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 30 Nov 2010

Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis – a double-blind comparison with sustained release mesalazine (Alimentary Pharmacology and Therapeutics 2011)